http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0410492-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8de36b670d924c98d9418de6133180
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
filingDate 2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_536416a1abfd1148c1f786dfa5a68d4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93da1decadc75c8ed272cc4107a0e3c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105b128b8dbd149016f31ed8dbf2d306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6872b2f649fd89466b2fa1a00c447d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a6ac6128cd28d893d579c02138ae54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b59e8cdc22a26335e2b3a48fd7901c9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5374d7fef345293826815bc6091a8625
publicationDate 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0410492-A
titleOfInvention humanized antibodies, method for inhibiting binding of interferon-i to receptor-1, for inhibiting an immune response, for treating an autoimmune disorder, for modifying serum crp levels, for serum neopterin levels and for modifying proliferation of b-cells, and chimeric antibody
abstract "HUMANIZED ANTIBODIES, METHOD FOR INHIBITING INTERFERON-I CONNECTION-1 BINDING, FOR INHIBITION OF AN IMMUNE RESPONSE, TO TREAT AUTOIMMUN DISORDER, TO MODIFY SERP CRP LEVELS FOR NEOPTERINE MODIFYER LEOPHERIN B-CELL AND CHEMICAL ANTIBODY ". Humanized IFNAR-1-binding monoclonal antibodies, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising humanized antibodies and therapeutic and diagnostic methods for using humanized antibodies.
priorityDate 2003-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135460965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135408877

Total number of triples: 44.